The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine

October 12, 2020NewsHepatitis C Virus, nobel prize, virusbiolabs

The 2020 Nobel Prize in Physiology or Medicine is awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus”. Thanks to their discovery,Read More…

COVID-19 May Lead to the Loss of Important Immune Structure—It Is Expected to Explain the Cause of Secondary Infection in Recovered Patients

September 2, 2020Biological Knowledge, NewsCOVID-19, Immune Response, virusbiolabs

According to the latest report from the Science, four research institutions, including Massachusetts Institute of Technology and Harvard University, conducted an autopsy analysis on patients who died of COVID-19 and found thatRead More…

Cell: Isolated Strong SARS-CoV-2 Neutralizing Antibody from Patients with COVID-19

July 13, 2020Drug Discovery Research, NewsAntibody Discovery, COVID-19biolabs

An important line of defense against novel coronavirus SARS-CoV-2 is the formation of neutralizing antibodies. These antibodies can eliminate invaders and have great potential in the prevention and treatment of SARS-CoV-2 infection.Read More…

Big News! Microbes Control the Health of the Immune System!

May 14, 2020Biological Knowledge, Immunotherapy Research, NewsConventional Dendriticcells, Immune System, immunotherapybiolabs

Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…

National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19

March 17, 2020NewsCOVID-19, virusbiolabs

Nebraska is conducting the first clinical trial of possible coronavirus treatment, which is expected to eventually include 400 patients in 50 locations around the world, officials said. In this international study, halfRead More…

Summary of New Drugs with Clinical Trial Progress Approved by FDA in 2019

January 15, 2020Drug Discovery Research, NewsAntibiotics, Diagnostic Reagents, New Drugs, Targeted Drugsbiolabs

Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…

Comprehensive Analysis of Targeted Drugs for Lung Cancer

October 11, 2019Drug Discovery Research, Immunotherapy Research, Newsimmunotherapy, monoclonal antibody, Small molecule targeted drugsbiolabs

Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…

Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation

September 17, 2019Antibody Engineering Research, NewsCell Characterization, Nanotechnology, Stem Cell Transplantationbiolabs

In a study published in the international journal ACS Nano, scientists from Rutgers University have developed a new nanotechnology. It may accelerate the research in the field of stem cell transplantation andRead More…

Monoclonal Drug Development and Market Conditions

June 19, 2019Biological Knowledge, Newsantibody development, Antibody Discovery, monoclonal antibody, Therapeutic Antibodybiolabs

B lymphocytes can only produce a proprietary antibody against an antigen determinant, so it has the characteristics of highly specific physical and chemical properties, single biological activity, strong binding specificity with antigenRead More…

Antibodies Cure Guinea Pigs Infected with Ebola Virus, Raising Hopes for Human Treatment of Ebola

May 16, 2019Drug Discovery Research, NewsAntibody Discovery, Human Antibody, Therapeutic Antibodybiolabs

The outbreak of Ebola in 2014 in West Africa killed more than 11000 people. At the time, scientists were working on several experimental vaccines and treatments, but none of them were approvedRead More…